Severity
Moderate
FDA Drug recall · Reported December 4, 2024
CGMP violations.
Neogen Corporation recalled LICEOUT, Liquid Lice Treatment for Human Use, Contents: 128 FL OZ. (3785.4 mL mL) per jug… - a moderate-severity action.
LICEOUT, Liquid Lice Treatment for Human Use, Contents: 128 FL OZ. (3785.4 mL mL) per jug… was recalled by Neogen Corporation in December 4, 2024. Reason: CGMP violations.. Check the official notice for the remedy. Verify recall #D-0074-2025 with the FDA Drug before acting.
The recall
Neogen Corporation issued this moderate-severity FDA Drug recall-CGMP violations..
Sourced from official FDA Drug enforcement records. Verify recall #D-0074-2025 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0074-2025) was formally reported on December 4, 2024, with the manufacturer initiating the action on October 8, 2024. It is classified under Moderate severity (Class II), with a current status of Ongoing. Neogen Corporation is listed as the recalling firm, operating out of Lexington, KY. Federal records list the affected scope as 8,328 jugs.
The documented reason for this recall is: CGMP violations. Distribution data in the federal record shows the product reached: Product sold directly to one distributor consignee, Bob Barker Company, an American company that sells supplies to prisons, jails, and other institutions.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
8,328 jugs
Related Recalls
6
5 from same agency
LICEOUT, Liquid Lice Treatment for Human Use, Contents: 128 FL OZ. (3785.4 mL mL) per jug, Distributed By: Bob Barker Company, Inc., 7925 Purfoy Road, Fuquay-Varina, NC 27526. NDC: 53247-124-02
CGMP violations.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Ongoing |
| Recall number | D-0074-2025 |
| Date reported | December 4, 2024 |
| Date initiated | October 8, 2024 |
| Recalling firm | Neogen Corporation |
| Firm location | Lexington, KY |
| Affected scope | 8,328 jugs |
| Distribution | Product sold directly to one distributor consignee, Bob Barker Company, an American company that sells supplies to prisons, jails, and other institutions. |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported December 4, 2024. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.